On February 9, the U.S. Food and Drug Administration (FDA) cleared for marketing the ENROUTE Transcarotid Neuroprotection System (ENROUTE TNS) for use during carotid angioplasty and stenting. It’s the first device designed to access the carotid arteries through an incision in the neck, instead of the groin, and uses a blood flow reversal system to capture pieces of the blockage dislodged during the procedure. Read more.
FDA clears system to reduce stroke risk during carotid stent, angioplasty procedures
The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal. This has not been peer reviewed.
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
